Oncology Drug Shortages: Impacts, Policy Reforms, and Advocacy Imperatives

Marissa Malta1, Matthew Christian, Amy B Cadwallader

  • 1US Pharmacopeia, Global External Affairs, 12601 Twinbrook Parkway, Rockville, MD.

PubMed

Insights

Oncology drug shortages are critically impacting cancer patient care. This study analyzes supply chain issues and proposes policy reforms for sustainable pharmaceutical supply chain resilience.

Area of Science:

  • Oncology
  • Pharmaceutical Sciences
  • Health Policy

Background:

  • Oncology drug shortages have reached unprecedented levels.
  • These shortages significantly impact cancer patient treatment, leading to rationing, delays, and suboptimal therapies.

Purpose of the Study:

  • To outline systemic drivers of pharmaceutical supply chain vulnerabilities causing drug shortages.
  • To present data analyses of ongoing oncology drug shortages.
  • To propose actionable policy reforms for patient advocacy and supply chain resilience.

Main Methods:

  • Systemic analysis of supply chain vulnerabilities.
  • Data analysis of current medicine supply chain shortages.
  • Development of policy recommendations for pharmaceutical supply chain reform.

Main Results:

  • Identified key systemic drivers contributing to oncology drug shortages.
  • Analyzed current trends and patterns in medicine supply chain disruptions.
  • Formulated policy recommendations to enhance pharmaceutical supply chain sustainability.

Conclusions:

  • Addressing systemic vulnerabilities is crucial for mitigating oncology drug shortages.
  • Policy reforms are necessary to ensure patient access to essential cancer treatments.
  • Building a resilient pharmaceutical supply chain requires sustainable, long-term strategies.

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Drug Control Governance: Regulatory Bodies and Their Impact01:03

Drug Control Governance: Regulatory Bodies and Their Impact

Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
495
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
6.1K
Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.2K